StockData

Eton Pharmaceuticals vs Rockwell Medical

ETON and RMTI side by side, both in drugs. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.

How ETON and RMTI compare

Eton Pharmaceuticals is the larger company, worth 68 times as much as Rockwell Medical ($1.8B against $26.6M).

Eton Pharmaceuticals grew revenue faster over the last twelve months (81.5% versus −21.1% for Rockwell Medical).

Eton Pharmaceuticals keeps more of each dollar of sales as profit, with a net margin of 12.0% compared with −7.3% at Rockwell Medical.

Rockwell Medical scores higher on the StockData Score (11 against 10 for Eton Pharmaceuticals), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.

Key numbers

A dot marks the better figure where higher or lower is clearly better.

MetricETONRMTI
Size and price
Market cap$1.8B$26.6M
Share price$63.65$6.61
Change, 1 year276%−28.1%
Change, 5 years1408%−86.3%
Beta (5Y)−0.440.01
Employees44157
StockData Score
Total score1011 (better)
Valuation score03 (better)
Growth score3 (better)1
Performance score4 (better)3
Health score34 (better)
Dividend score00
Valuation
P/E163×–
P/S17.2×0.4× (better)
P/B39.1×0.8× (better)
EV/EBITDA87.3×–
P/FCF123×17.3× (better)
FCF yield0.81%5.8% (better)
Fair value$10.20$32.27
Margin of safety−524%79.5% (better)
Growth
Revenue growth (TTM)81.5% (better)−21.1%
Revenue growth, 5Y average360% (better)2.2%
Profitability
Gross margin57.9% (better)17.7%
Operating margin15.4% (better)−6.5%
Net margin12.0% (better)−7.3%
FCF margin14.0% (better)2.2%
Return on equity36.0% (better)−15.5%
Return on invested capital42.5% (better)−17.9%
Financial health
Debt / equity0.600.26 (better)
Net debt / EBITDA0.05–
Interest coverage3.6× (better)−4.0×
Current ratio1.523.25 (better)
Altman Z-score16.19 (better)−7.81
Piotroski F-score4 (better)2
Dividends and buybacks
Shareholder yield0.00%0.00%
Ownership
Held by institutions74.0%0.05%
Held by insiders5.6%100%
Insider net buying, 12 months−$35.0M−$11.6K (better)
Short interest, % of float7.4%–

Go deeper

For information only, not investment advice. Check the source filings before relying on any figure.